UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBPH
2051
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.84M | ﹤0.01% |
55,079
+5,023
| +10% | +$173K |
|
2052
SoundHound AI
SOUN
$3.49B
| $1.84M | ﹤0.01% |
393,858
-39,989
| -9% | -$193K |
|
2053
Barrett Business Services
BBSI
$804M
| $1.83M | ﹤0.01% |
48,827
-9,153
| -16% | -$322K |
|
2054
Genco Shipping & Trading
GNK
$1.1B
| $1.83M | ﹤0.01% |
93,903
-2,643
| -3% | -$49.3K |
|
2055
AdaptHealth
AHCO
$759M
| $1.82M | ﹤0.01% |
162,470
+11,757
| +8% | +$125K |
|
2056
Wabash National
WNC
$527M
| $1.82M | ﹤0.01% |
95,032
-2,346
| -2% | -$47.2K |
|
2057
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
| $1.82M | ﹤0.01% |
+48,333
| New | +$1.79M |
|
2058
Amneal Pharmaceuticals
AMRX
$5.79B
| $1.82M | ﹤0.01% |
218,554
-46,170
| -17% | -$361K |
|
2059
BrightView Holdings
BV
$1.07B
| $1.82M | ﹤0.01% |
115,435
-7,731
| -6% | -$112K |
|
2060
Blue Bird Corp
BLBD
$2.18B
| $1.81M | ﹤0.01% |
37,746
-4,069
| -10% | -$201K |
|
2061
MoonLake Immunotherapeutics
MLTX
$1.55B
| $1.81M | ﹤0.01% |
35,814
+17,580
| +96% | +$824K |
|
|
KREF
2062
KKR Real Estate Finance Trust
KREF
$499M
| $1.8M | ﹤0.01% |
145,896
+86,327
| +145% | +$966K |
|
2063
Shutterstock
SSTK
$219M
| $1.79M | ﹤0.01% |
50,746
-11,627
| -19% | -$429K |
|
2064
Equinox Gold
EQX
$13.5B
| $1.79M | ﹤0.01% |
294,574
-45,791
| -13% | -$259K |
|
|
FLNA
2065
Filana Therapeutics
FLNA
$48.1M
| $1.79M | ﹤0.01% |
60,894
-13,075
| -18% | -$301K |
|
2066
Establishment Labs
ESTA
$2.28B
| $1.79M | ﹤0.01% |
41,351
+19,531
| +90% | +$849K |
|
2067
Sphere Entertainment
SPHR
$5.73B
| $1.79M | ﹤0.01% |
40,481
-4,054
| -9% | -$174K |
|
2068
Enviri
NVRI
$620M
| $1.79M | ﹤0.01% |
172,781
-24,280
| -12% | -$256K |
|
2069
AMERISAFE
AMSF
$540M
| $1.78M | ﹤0.01% |
36,924
-9,022
| -20% | -$429K |
|
2070
Preferred Bank
PFBC
$1.25B
| $1.78M | ﹤0.01% |
22,161
-1,117
| -5% | -$89.2K |
|
2071
QuinStreet
QNST
$1.21B
| $1.78M | ﹤0.01% |
92,821
-16,685
| -15% | -$304K |
|
2072
Phathom Pharmaceuticals
PHAT
$692M
| $1.77M | ﹤0.01% |
98,025
+4,871
| +5% | +$68.1K |
|
2073
TORM
TRMD
$3.02B
| $1.77M | ﹤0.01% |
51,782
-1,439
| -3% | -$52.8K |
|
|
ETWO
2074
DELISTED
E2open Parent Holdings
ETWO
| $1.77M | ﹤0.01% |
400,979
-44,527
| -10% | -$195K |
|
|
KE
2075
Kimball Electronics
KE
$628M
| $1.77M | ﹤0.01% |
95,526
+556
| +0.6% | +$11.1K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.